APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibody Services

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

Selected research

Market Outlook & Growth Opportunities

Global Antibody Services Market Outlook and Growth Opportunities 2026

25 December 2025198 pages

Choose your research edition.

Industry ResearchAntibody Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibody Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Antibody Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibody Services Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibody Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

Thermo Fisher ranks the first in terms of revenue share in global market of Antibody Services, occupies 18% of the global market share. While, Covance, with a market share of 14%, comes the second. All the other manufacturers which are not included in the report together consist of approximately 46% of the global market.

North America ranks the top in terms of market size of Antibody Services, which alone consists of 40% of the global market. Europe comes the second, with 31% of the global market. Asia Pacific ranks the third, consists of about 18% of the global antibody service market in the same year. All the other regions combined occupy only 8% of the global Antibody Service market.

Read the full market overview

This report provides an overview of the global Antibody Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antibody Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antibody Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Antibody Services market.

Antibody Services Segment by Company

ThermoFisher

GenScript

Abcam

MBS

ROCKLAND

ProSci

Anaspec

Bio-Rad

Covance

Capra Science

Innovagen

APS

Randox

GL Biochem

Abgent

Antibody Services Segment by Type

Monoclonal

Polyclonal

Others

Antibody Services Segment by Application

BioScience Companies

BioScience Research Institutions

Hospitals

Other

Antibody Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antibody Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Antibody Services key companies, revenue, market share, and recent developments.

3. To split the Antibody Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Antibody Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antibody Services significant trends, drivers, influence factors in global and regions.

6. To analyze Antibody Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antibody Services industry.

Chapter 3: Detailed analysis of Antibody Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Antibody Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Antibody Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antibody Services Industry Trends Table 2. Antibody Services Industry Drivers Table 3. Antibody Services Industry Opportunities and Challenges Table 4. Antibody Services Industry Restraints Table 5. Global Antibody Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antibody Services Revenue Share by Company (2021-2026) Table 7. Global Antibody Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Antibody Services Key Company Manufacturing Base & Headquarters Table 9. Global Antibody Services Company, Product Type & Application Table 10. Global Antibody Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Antibody Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Monoclonal Table 15. Significant Companies of Polyclonal Table 16. Significant Companies of Others Table 17. Global Antibody Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Antibody Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Antibody Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Antibody Services Sales Value Share by Type (2021-2026) Table 21. Global Antibody Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of BioScience Companies Table 23. Significant Companies of BioScience Research Institutions Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Other Table 26. Global Antibody Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Antibody Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Antibody Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Antibody Services Sales Value Share by Application (2021-2026) Table 30. Global Antibody Services Sales Value Share by Application (2027-2032) Table 31. Global Antibody Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Antibody Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Antibody Services Sales Value Share by Region (2021-2026) Table 34. Global Antibody Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Antibody Services Sales Value Share by Region (2027-2032) Table 36. Global Antibody Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Antibody Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Antibody Services Sales Value Market Share by Country (2021-2026) Table 39. Global Antibody Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Antibody Services Sales Value Market Share by Country (2027-2032) Table 41. ThermoFisher Company Information Table 42. ThermoFisher Business Overview Table 43. ThermoFisher Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. ThermoFisher Antibody Services Product Portfolio Table 45. ThermoFisher Recent Development Table 46. GenScript Company Information Table 47. GenScript Business Overview Table 48. GenScript Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. GenScript Antibody Services Product Portfolio Table 50. GenScript Recent Development Table 51. Abcam Company Information Table 52. Abcam Business Overview Table 53. Abcam Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Abcam Antibody Services Product Portfolio Table 55. Abcam Recent Development Table 56. MBS Company Information Table 57. MBS Business Overview Table 58. MBS Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. MBS Antibody Services Product Portfolio Table 60. MBS Recent Development Table 61. ROCKLAND Company Information Table 62. ROCKLAND Business Overview Table 63. ROCKLAND Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. ROCKLAND Antibody Services Product Portfolio Table 65. ROCKLAND Recent Development Table 66. ProSci Company Information Table 67. ProSci Business Overview Table 68. ProSci Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. ProSci Antibody Services Product Portfolio Table 70. ProSci Recent Development Table 71. Anaspec Company Information Table 72. Anaspec Business Overview Table 73. Anaspec Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Anaspec Antibody Services Product Portfolio Table 75. Anaspec Recent Development Table 76. Bio-Rad Company Information Table 77. Bio-Rad Business Overview Table 78. Bio-Rad Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Bio-Rad Antibody Services Product Portfolio Table 80. Bio-Rad Recent Development Table 81. Covance Company Information Table 82. Covance Business Overview Table 83. Covance Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Covance Antibody Services Product Portfolio Table 85. Covance Recent Development Table 86. Capra Science Company Information Table 87. Capra Science Business Overview Table 88. Capra Science Antibody Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Capra Science Antibody Services Product Portfolio Table 90. Capra Science Recent Development Table 91. Innovagen Company Information Table 92. Innovagen Business Overview Table 93. Innovagen Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Innovagen Antibody Services Product Portfolio Table 95. Innovagen Recent Development Table 96. APS Company Information Table 97. APS Business Overview Table 98. APS Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. APS Antibody Services Product Portfolio Table 100. APS Recent Development Table 101. Randox Company Information Table 102. Randox Business Overview Table 103. Randox Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Randox Antibody Services Product Portfolio Table 105. Randox Recent Development Table 106. GL Biochem Company Information Table 107. GL Biochem Business Overview Table 108. GL Biochem Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. GL Biochem Antibody Services Product Portfolio Table 110. GL Biochem Recent Development Table 111. Abgent Company Information Table 112. Abgent Business Overview Table 113. Abgent Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Abgent Antibody Services Product Portfolio Table 115. Abgent Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Antibody Services Product Image Figure 2. Global Antibody Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibody Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibody Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Monoclonal Image Figure 8. Polyclonal Image Figure 9. Others Image Figure 10. Global Antibody Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Antibody Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Antibody Services Sales Value Share by Type (2021-2032) Figure 13. BioScience Companies Image Figure 14. BioScience Research Institutions Image Figure 15. Hospitals Image Figure 16. Other Image Figure 17. Global Antibody Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Antibody Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Antibody Services Sales Value Share by Application (2021-2032) Figure 20. Global Antibody Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Antibody Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Antibody Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Antibody Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Antibody Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Antibody Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Antibody Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Antibody Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Antibody Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Antibody Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Antibody Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Antibody Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Antibody Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Antibody Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Antibody Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal
  • Polyclonal
  • Others
Applications
  • BioScience Companies
  • BioScience Research Institutions
  • Hospitals
  • Other
Companies covered
  • ThermoFisher
  • GenScript
  • Abcam
  • MBS
  • ROCKLAND
  • ProSci
  • Anaspec
  • Bio-Rad
  • Covance
  • Capra Science
  • Innovagen
  • APS
  • Randox
  • GL Biochem
  • Abgent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antibody Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antibody Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Antibody Services Market Dynamics
  1. 2.1 Antibody Services Industry Trends
  2. 2.2 Antibody Services Industry Drivers
  3. 2.3 Antibody Services Industry Opportunities and Challenges
  4. 2.4 Antibody Services Industry Restraints
3 Antibody Services Market by Company
  1. 3.1 Global Antibody Services Company Revenue Ranking in 2025
  2. 3.2 Global Antibody Services Revenue by Company (2021-2026)
  3. 3.3 Global Antibody Services Company Ranking (2024-2026)
  4. 3.4 Global Antibody Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Antibody Services Company Product Type and Application
  6. 3.6 Global Antibody Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Antibody Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Antibody Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Antibody Services Market by Type
  1. 4.1 Antibody Services Type Introduction
  2. 4.1.1 Monoclonal
  3. 4.1.2 Polyclonal
  4. 4.1.3 Others
  5. 4.2 Global Antibody Services Sales Value by Type
  6. 4.2.1 Global Antibody Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antibody Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Antibody Services Sales Value Share by Type (2021-2032)
5 Antibody Services Market by Application
  1. 5.1 Antibody Services Application Introduction
  2. 5.1.1 BioScience Companies
  3. 5.1.2 BioScience Research Institutions
  4. 5.1.3 Hospitals
  5. 5.1.4 Other
  6. 5.2 Global Antibody Services Sales Value by Application
  7. 5.2.1 Global Antibody Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antibody Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Antibody Services Sales Value Share by Application (2021-2032)
6 Antibody Services Regional Value Analysis
  1. 6.1 Global Antibody Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antibody Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Antibody Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Antibody Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antibody Services Sales Value (2021-2032)
  7. 6.3.2 North America Antibody Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Antibody Services Sales Value (2021-2032)
  10. 6.4.2 Europe Antibody Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Antibody Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Antibody Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Antibody Services Sales Value (2021-2032)
  16. 6.6.2 South America Antibody Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Antibody Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Antibody Services Sales Value Share by Country, 2025 VS 2032
7 Antibody Services Country-level Value Analysis
  1. 7.1 Global Antibody Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antibody Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Antibody Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Antibody Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Antibody Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Antibody Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Antibody Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Antibody Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Antibody Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Antibody Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Antibody Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Antibody Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Antibody Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Antibody Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Antibody Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Antibody Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Antibody Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Antibody Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Antibody Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Antibody Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Antibody Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Antibody Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Antibody Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Antibody Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Antibody Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Antibody Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Antibody Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Antibody Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Antibody Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Antibody Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Antibody Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Antibody Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Antibody Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Antibody Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Antibody Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Antibody Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Antibody Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Antibody Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Antibody Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Antibody Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Antibody Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Antibody Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Antibody Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Antibody Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Antibody Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Antibody Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Antibody Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Antibody Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Antibody Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Antibody Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Antibody Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Antibody Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Antibody Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Antibody Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Antibody Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Antibody Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Antibody Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Antibody Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Antibody Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Antibody Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Antibody Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Antibody Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Antibody Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Antibody Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Antibody Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Antibody Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Antibody Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Antibody Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Antibody Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Antibody Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Antibody Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Antibody Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Antibody Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Antibody Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Antibody Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Antibody Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Antibody Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Antibody Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Antibody Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Antibody Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Antibody Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Antibody Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Antibody Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Antibody Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Antibody Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Antibody Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Antibody Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Antibody Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ThermoFisher
  2. 8.1.1 ThermoFisher Company Information
  3. 8.1.2 ThermoFisher Business Overview
  4. 8.1.3 ThermoFisher Antibody Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ThermoFisher Antibody Services Product Portfolio
  6. 8.1.5 ThermoFisher Recent Developments
  7. 8.2 GenScript
  8. 8.2.1 GenScript Company Information
  9. 8.2.2 GenScript Business Overview
  10. 8.2.3 GenScript Antibody Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GenScript Antibody Services Product Portfolio
  12. 8.2.5 GenScript Recent Developments
  13. 8.3 Abcam
  14. 8.3.1 Abcam Company Information
  15. 8.3.2 Abcam Business Overview
  16. 8.3.3 Abcam Antibody Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Abcam Antibody Services Product Portfolio
  18. 8.3.5 Abcam Recent Developments
  19. 8.4 MBS
  20. 8.4.1 MBS Company Information
  21. 8.4.2 MBS Business Overview
  22. 8.4.3 MBS Antibody Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MBS Antibody Services Product Portfolio
  24. 8.4.5 MBS Recent Developments
  25. 8.5 ROCKLAND
  26. 8.5.1 ROCKLAND Company Information
  27. 8.5.2 ROCKLAND Business Overview
  28. 8.5.3 ROCKLAND Antibody Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ROCKLAND Antibody Services Product Portfolio
  30. 8.5.5 ROCKLAND Recent Developments
  31. 8.6 ProSci
  32. 8.6.1 ProSci Company Information
  33. 8.6.2 ProSci Business Overview
  34. 8.6.3 ProSci Antibody Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ProSci Antibody Services Product Portfolio
  36. 8.6.5 ProSci Recent Developments
  37. 8.7 Anaspec
  38. 8.7.1 Anaspec Company Information
  39. 8.7.2 Anaspec Business Overview
  40. 8.7.3 Anaspec Antibody Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Anaspec Antibody Services Product Portfolio
  42. 8.7.5 Anaspec Recent Developments
  43. 8.8 Bio-Rad
  44. 8.8.1 Bio-Rad Company Information
  45. 8.8.2 Bio-Rad Business Overview
  46. 8.8.3 Bio-Rad Antibody Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Rad Antibody Services Product Portfolio
  48. 8.8.5 Bio-Rad Recent Developments
  49. 8.9 Covance
  50. 8.9.1 Covance Company Information
  51. 8.9.2 Covance Business Overview
  52. 8.9.3 Covance Antibody Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Covance Antibody Services Product Portfolio
  54. 8.9.5 Covance Recent Developments
  55. 8.10 Capra Science
  56. 8.10.1 Capra Science Company Information
  57. 8.10.2 Capra Science Business Overview
  58. 8.10.3 Capra Science Antibody Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Capra Science Antibody Services Product Portfolio
  60. 8.10.5 Capra Science Recent Developments
  61. 8.11 Innovagen
  62. 8.11.1 Innovagen Company Information
  63. 8.11.2 Innovagen Business Overview
  64. 8.11.3 Innovagen Antibody Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Innovagen Antibody Services Product Portfolio
  66. 8.11.5 Innovagen Recent Developments
  67. 8.12 APS
  68. 8.12.1 APS Company Information
  69. 8.12.2 APS Business Overview
  70. 8.12.3 APS Antibody Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 APS Antibody Services Product Portfolio
  72. 8.12.5 APS Recent Developments
  73. 8.13 Randox
  74. 8.13.1 Randox Company Information
  75. 8.13.2 Randox Business Overview
  76. 8.13.3 Randox Antibody Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Randox Antibody Services Product Portfolio
  78. 8.13.5 Randox Recent Developments
  79. 8.14 GL Biochem
  80. 8.14.1 GL Biochem Company Information
  81. 8.14.2 GL Biochem Business Overview
  82. 8.14.3 GL Biochem Antibody Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GL Biochem Antibody Services Product Portfolio
  84. 8.14.5 GL Biochem Recent Developments
  85. 8.15 Abgent
  86. 8.15.1 Abgent Company Information
  87. 8.15.2 Abgent Business Overview
  88. 8.15.3 Abgent Antibody Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Abgent Antibody Services Product Portfolio
  90. 8.15.5 Abgent Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst